Military Hospital of Tunis Report issue

Government Phase 3 Phase 4

Organization Overview

First Clinical Trial
2017
NCT04376970
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Department of C ritical C are Medicine and Anesthesiology, Military Hospital of Tunis, Tunisia, Tunis, Tunisia | Military Hospital of Tunis

Active Ingredients

Drugs in Phase 4 Trials (2)

cyclosporine (sandimmune) (1 trial)

fluconazole (diflucan) (1 trial)

Drugs in Phase 3 Trials (2)

hydroxychloroquine (plaquenil) (1 trial)

zinc (1 trial)

Drugs in Other Trials (1)

remifentanil (ultiva) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infections (Phase 3)

Keratoconjunctivitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5